Top Sell
| Security | Buy | Sell | Buy (1M) | Sell (1M) ▼ | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Kala Pharmaceuticals Inc. | 12 | 4 | 0 | 3 | €0.81 | €13.19 | 1530.717% |
| Novavax Inc. | 9 | 5 | 1 | 2 | €5.93 | €9.03 | 52.352% |
| Baxter International | 7 | 3 | 0 | 1 | €15.92 | €36.53 | 129.483% |
| Larimar Therapeutics Inc. | 0 | 1 | 0 | 0 | €3.10 | - | - |
| MicroVision Inc | 12 | 1 | 1 | 0 | €0.79 | €2.06 | 162.159% |
| Formycon AG | 1 | 1 | 0 | 0 | €25.50 | - | - |
| Organovo Holdings Inc. | 0 | 8 | 0 | 0 | €0.26 | - | - |
| Promis Neurosciences Inc. | 0 | 1 | 0 | 0 | €0.27 | - | - |
| Cellectar BioSciences Inc. | 2 | 7 | 0 | 0 | €0.26 | - | - |
| Immunic Inc. | 23 | 1 | 3 | 0 | €0.58 | €8.68 | 1406.771% |
| Pulse Biosciences Inc | 1 | 2 | 0 | 0 | €11.10 | €18.69 | 68.350% |
| Teleflex Inc. | 5 | 1 | 0 | 0 | €100.00 | €165.01 | 65.011% |
| Amarin Corp. ADR | 0 | 6 | 0 | 0 | €0.41 | €8.24 | 1919.461% |
| SCYNEXIS Inc. | 1 | 2 | 0 | 0 | €0.57 | €2.57 | 354.664% |
| Novo Nordisk A/S ADR | 17 | 1 | 1 | 0 | €41.10 | €72.54 | 76.498% |
| Cardiff Oncology Inc. | 1 | 1 | 0 | 0 | €1.86 | - | - |
| Nanorepro AG | 0 | 1 | 0 | 0 | €1.56 | - | - |
| Hutchison China MediTech Ltd ADR | 3 | 1 | 1 | 0 | €11.90 | €17.84 | 49.876% |
| Fresenius Medical Care AG & Co KGaA ADR | 1 | 4 | 1 | 0 | €20.20 | - | - |
| TG Therapeutics Inc. | 5 | 3 | 0 | 0 | €26.42 | €51.29 | 94.162% |
| Vivoryon Therapeutics N.V. | 0 | 1 | 0 | 0 | €1.61 | - | - |
| Geratherm Medical AG | 1 | 1 | 0 | 0 | €3.15 | - | - |
| Integra LifeSciences Holdings Corp | 1 | 4 | 0 | 0 | €11.50 | €10.62 | -7.610% |
| CEL-SCI Corp. | 0 | 5 | 0 | 0 | €0.18 | - | - |
| X T L Biopharmaceuticals Ltd ADR | 0 | 1 | 0 | 0 | €0.68 | - | - |